John Hancock Multifactor ... (JHMH)
AMEX: JHMH
· Real-Time Price · USD
45.42
0.69 (1.54%)
At close: Oct 24, 2022, 9:03 PM
1.54% (1D)
| Bid | - |
| Market Cap | 20.44M |
| AUM | 20.34M |
| NAV | 45.19 |
| EPS (ttm) | 0.00 |
| PE Ratio (ttm) | n/a |
| Shares Out | 450K |
| Inception Date | Sep 28, 2015 |
| Ask | - |
| Volume | 16.92K |
| Open | 44.88 |
| Previous Close | 44.73 |
| Day's Range | 44.88 - 45.47 |
| 52-Week Range | 44.88 - 45.47 |
| Holdings | 148 |
| Expense Ratio | 0.40% |
About JHMH
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities that compose the fund's index. The index is designed to comprise securities in the healthcare sector within the U.S. Universe whose market capitalizations are larger than that of the 1001st largest U.S. company at the time of reconstitution. The fund is non-diversified.
Asset Class Equity
Ticker Symbol JHMH
Inception Date Sep 28, 2015
Provider John Hancock
Website Fund Home Page
Exchange AMEX
Top Sectors
| Sector | Weight % |
|---|---|
| Healthcare | 98.97% |
| Consumer Cyclical | 0.58% |
| Basic Materials | 0.45% |
Top 10 Holdings 30.35% of assets
| Name | Symbol | Weight |
|---|---|---|
| Unitedhealth Group I... | UNH | 6.00% |
| Johnson & Johnson | JNJ | 5.55% |
| Pfizer Inc. | PFE | 2.97% |
| Merck & Co., Inc. | MRK | 2.84% |
| Thermo Fisher Scient... | TMO | 2.35% |
| Abbvie Inc. | ABBV | 2.23% |
| Eli Lilly And Compan... | LLY | 2.22% |
| Abbott Laboratories | ABT | 2.17% |
| Elevance Health Inc. | ANTM | 2.02% |
| Bristol-myers Squibb... | BMY | 2.00% |
Dividends Dividend Yield 0.78%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 27, 2022 | $0.1540 | Jun 30, 2022 |
| Dec 27, 2021 | $0.2080 | Dec 30, 2021 |
| Jun 25, 2021 | $0.1670 | Jun 30, 2021 |
| Dec 24, 2020 | $0.6430 | Dec 30, 2020 |
| Jun 25, 2020 | $0.4500 | Jun 30, 2020 |
4 years ago · seekingalpha.com
Healthcare: A Wide Choice Of Large And Well-Established CompaniesThe advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...
